Haitong Securities: The moderate price reduction of traditional Chinese medicine varieties continues. The domestic pharmaceutical industry is expected to set off a wave of mergers and acquisitions. Haitong Securities released a research report saying that the moderate price reduction of traditional Chinese medicine varieties continues. In 2024, the traditional Chinese medicine industry was under pressure due to the pressure of pharmacy terminal sales and inventory pressure, and it is expected to return to a good situation in the next 25 years. In addition, the continuous technological changes in the pharmaceutical industry, the development of IPO to mergers and acquisitions and the promotion of corporate governance optimization at the shareholder level are the main reasons for promoting mergers and acquisitions in the industry. In terms of fields, mergers and acquisitions are expected to occur intensively in sub-sectors such as medical devices, Chinese medicine, medical services, blood products and scientific research services.Pfizer announced an increase in its quarterly dividend, and American pharmaceutical giant Pfizer said on Thursday that it would increase its quarterly dividend by 2.4%, from 42 cents to 43 cents per share. The new dividend is equivalent to $1.72 per year, which means that the annual yield is about 6.8%. Albert Bourla, CEO of Pfizer, said that the dividend increase highlighted the company's strong financial performance, execution and commitment to return capital to shareholders.Broadcom: The artificial intelligence semiconductor business will surpass other businesses.
Industry: Concerns about the imbalance between supply and demand still exist, and there is limited room for alumina futures to continue to fall. Since the intraday record of 5,540 yuan/ton on December 5, the main contract price of domestic alumina futures has started to fluctuate and fall, reaching a minimum of 5,077 yuan/ton on December 12, with the cumulative maximum decline exceeding 8%. According to industry insiders, the increase of alumina registered delivery brands and the sharp drop in overseas alumina spot quotations have led to the recent decline in alumina futures prices. Although the short-term news in the market is intertwined, the imbalance between supply and demand in the alumina market has not fundamentally improved, so there is limited room for the subsequent decline of alumina futures prices. (CSI)Sources: Boeing (BA.N) is expected to deliver the new Air Force One after Trump's next term.Blinken: Providing 500 million U.S. dollars in aid to Ukraine. U.S. Secretary of State Blinken said that he would provide Ukraine with a 500 million U.S. dollar aid package, which includes providing "Haima" ammunition and unmanned aerial vehicle systems.
Apple is reported to cooperate with Broadcom to develop AI chips, and TSMC's advanced process will welcome big orders again. On December 13, it was reported that Apple intends to invest in self-developed AI chips, jointly develop them with Broadcom, and produce them in TSMC's 3 nm process, and mass-produce them in 2026. The legal person is optimistic that after the development of Apple's self-developed AI chip is completed, the investment is expected, and TSMC's advanced process will usher in another big order. It is understood that Apple's current A-series processors for iPhone and M-series processors for Mac all adopt self-developed strategies, and are exclusively manufactured by TSMC. The legal person believes that once Apple's self-developed chips are extended to AI chips, the cooperation with TSMC will be closer. (Taiwan Province Economic Daily)Amco: agreed to buy 2,000 bitcoin mining machines from Canaan Creative Global.Suspected of misleading investors and being accused of bundling sales, NVIDIA is frequently involved in anti-monopoly investigations around the world. After China filed an anti-monopoly investigation against NVIDIA a few days ago, on the 12th, this artificial intelligence chip manufacturing giant was once again involved in the judicial turmoil. The US Supreme Court allowed investors to file a class action lawsuit against chipmaker NVIDIA, and rejected NVIDIA's appeal. This is the latest judicial dispute that NVIDIA has fallen into since the French, European Union and China launched an "anti-monopoly investigation" against NVIDIA.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide